ArticleBMC health services research2026
Outpatient reimbursement policies for cancer treatment in China: a comparative and longitudinal analysis.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Financial Relief and Health Effects of Urban-Rural Health Insurance Integration on Older Rural Adults: A Causal Analysis of Age-Based Heterogeneity.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCancer poses a huge health and economic burden globally, with China being no exception. While China’s basic medical insurance (BMI) program has expanded outpatient coverage for chronic diseases, including cancer, there is a lack of national-level guiding policies. This study aims to investigate disparities and inequities in outpatient cancer reimbursement across China by analyzing reimbursement policies in different cities and under different medical insurance schemes.
methodsWe conducted a cross-sectional analysis of outpatient reimbursement policies for cancers in China in 2022, supplemented by a longitudinal policy analysis. Data were collected from 85 prefecture-level cities under two insurance schemes: The Urban Employee Basic Medical Insurance (UEBMI) and the Urban and Rural Resident Basic Medical Insurance (URRBMI). We analyzed three key indicators: deductible threshold, reimbursement ratio, and reimbursement cap, using descriptive statistics to assess disparities and correlate them with local GDP per capita.
resultsSignificant differences were observed in reimbursement caps and ratios between the two medical insurance schemes (P < 0.005 and P < 0.001, respectively). Only the reimbursement cap was positively correlated with GDP per capita under both schemes (rs = 0.27, P = 0.01 for UEBMI; rs = 0.36, P = 0.001 for URRBMI). Longitudinally, sample cities showed unchanged or lower deductible thresholds, while reimbursement ratios and caps either remained unchanged or increased.
conclusionsNational guidelines for outpatient cancer reimbursement are needed in China to facilitate local policy refinement and enhance outpatient reimbursement level, thereby promoting healthcare accessibility and equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.